XWELL ROA 2010-2025 | XWEL
Current and historical return on assets (ROA) values for XWELL (XWEL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| XWELL ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-06-30 | $-0.02B | $0.02B | -79.25% |
| 2025-03-31 | $-0.02B | $0.03B | -66.67% |
| 2024-12-31 | $-0.02B | $0.03B | -54.55% |
| 2024-09-30 | $-0.02B | $0.03B | -41.10% |
| 2024-06-30 | $-0.02B | $0.04B | -56.05% |
| 2024-03-31 | $-0.03B | $0.04B | -58.43% |
| 2023-12-31 | $-0.03B | $0.04B | -56.86% |
| 2023-09-30 | $-0.04B | $0.05B | -62.98% |
| 2023-06-30 | $-0.03B | $0.06B | -46.55% |
| 2023-03-31 | $-0.03B | $0.06B | -42.63% |
| 2022-12-31 | $-0.03B | $0.07B | -34.59% |
| 2022-09-30 | $-0.02B | $0.09B | -14.99% |
| 2022-06-30 | $0.00B | $0.10B | -2.55% |
| 2022-03-31 | $0.00B | $0.11B | 0.82% |
| 2021-12-31 | $0.00B | $0.13B | 3.23% |
| 2021-09-30 | $-0.01B | $0.13B | -11.86% |
| 2021-06-30 | $-0.03B | $0.12B | -24.47% |
| 2021-03-31 | $-0.08B | $0.12B | -89.26% |
| 2020-12-31 | $-0.09B | $0.10B | -133.82% |
| 2020-09-30 | $-0.08B | $0.08B | -167.68% |
| 2020-06-30 | $-0.08B | $0.06B | -218.67% |
| 2020-03-31 | $-0.03B | $0.03B | -92.80% |
| 2019-12-31 | $-0.02B | $0.03B | -62.69% |
| 2019-09-30 | $-0.02B | $0.03B | -61.76% |
| 2019-06-30 | $-0.02B | $0.03B | -56.30% |
| 2019-03-31 | $-0.02B | $0.04B | -49.28% |
| 2018-12-31 | $-0.04B | $0.03B | -110.14% |
| 2018-09-30 | $-0.04B | $0.03B | -97.67% |
| 2018-06-30 | $-0.04B | $0.04B | -82.63% |
| 2018-03-31 | $-0.05B | $0.04B | -75.50% |
| 2017-12-31 | $-0.03B | $0.07B | -40.00% |
| 2017-09-30 | $-0.02B | $0.07B | -28.57% |
| 2017-06-30 | $-0.02B | $0.07B | -32.71% |
| 2017-03-31 | $-0.03B | $0.08B | -44.26% |
| 2016-12-31 | $-0.02B | $0.08B | -47.76% |
| 2016-09-30 | $0.00B | $0.04B | -9.52% |
| 2016-06-30 | $-0.01B | $0.04B | -26.35% |
| 2016-03-31 | $-0.01B | $0.05B | -21.30% |
| 2015-12-31 | $-0.01B | $0.05B | -30.57% |
| 2015-09-30 | $-0.10B | $0.03B | -288.89% |
| 2015-06-30 | $-0.10B | $0.04B | -186.55% |
| 2015-03-31 | $-0.11B | $0.03B | -137.70% |
| 2014-12-31 | $-0.11B | $0.04B | -112.08% |
| 2014-09-30 | $-0.05B | $0.11B | -43.70% |
| 2014-06-30 | $-0.05B | $0.12B | -40.72% |
| 2014-03-31 | $-0.05B | $0.12B | -39.69% |
| 2013-12-31 | $-0.05B | $0.12B | -37.92% |
| 2013-09-30 | $-0.05B | $0.14B | -32.38% |
| 2013-06-30 | $-0.04B | $0.15B | -28.07% |
| 2013-03-31 | $-0.03B | $0.15B | -28.90% |
| 2012-12-31 | $-0.02B | $0.16B | -29.89% |
| 2012-09-30 | $-0.01B | $0.12B | -18.32% |
| 2012-06-30 | $0.00B | $0.00B | -88.89% |
| 2012-03-31 | $0.00B | $0.00B | -100.00% |
| 2011-12-31 | $0.00B | $0.01B | -75.00% |
| 2011-09-30 | $-0.01B | $0.00B | -142.86% |
| 2011-06-30 | $-0.01B | $0.00B | -140.00% |
| 2011-03-31 | $-0.01B | $0.00B | -142.86% |
| 2010-12-31 | $-0.01B | $0.01B | -183.33% |
| 2010-06-30 | $-0.01B | $0.01B | -320.00% |
| 2010-03-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.006B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.373B | 28.07 |
| CVS Health (CVS) | United States | $89.823B | 11.17 |
| Elevance Health (ELV) | United States | $69.805B | 9.39 |
| Cencora (COR) | United States | $58.879B | 19.61 |
| DiDi Global (DIDIY) | China | $28.380B | 30.15 |
| Labcorp Holdings (LH) | United States | $23.110B | 18.37 |
| Natera (NTRA) | United States | $22.048B | 0.00 |
| BioMerieux (BMXMF) | France | $17.636B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.729B | 0.00 |
| ICON (ICLR) | Ireland | $14.556B | 14.01 |
| Medpace Holdings (MEDP) | United States | $13.083B | 34.63 |
| Solventum (SOLV) | United States | $12.631B | 13.03 |
| CochLear (CHEOY) | Australia | $12.527B | 0.00 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Revvity (RVTY) | United States | $10.644B | 18.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $9.863B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.237B | 0.00 |
| Avantor (AVTR) | United States | $8.781B | 12.88 |
| Charles River Laboratories (CRL) | United States | $7.854B | 14.90 |
| HealthEquity (HQY) | United States | $7.700B | 33.73 |
| Bausch + Lomb (BLCO) | Canada | $5.147B | 34.62 |
| Sotera Health (SHC) | United States | $4.630B | 25.87 |
| BrightSpring Health Services (BTSG) | United States | $4.186B | 31.93 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.455B | 79.14 |
| Surgery Partners (SGRY) | United States | $3.057B | 38.45 |
| Alignment Healthcare (ALHC) | United States | $2.974B | 0.00 |
| Concentras Parent (CON) | United States | $2.966B | 18.81 |
| Organon (OGN) | United States | $2.436B | 2.65 |
| Premier (PINC) | United States | $2.104B | 19.50 |
| Progyny (PGNY) | United States | $1.940B | 41.02 |
| Ardent Health (ARDT) | United States | $1.863B | 7.19 |
| PACS (PACS) | United States | $1.817B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.518B | 25.71 |
| Pediatrix Medical (MD) | United States | $1.417B | 9.46 |
| Teladoc Health (TDOC) | United States | $1.276B | 0.00 |
| Omada Health (OMDA) | $1.240B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.132B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.812B | 4.76 |
| AMN Healthcare Services Inc (AMN) | United States | $0.778B | 9.62 |
| CareDx (CDNA) | United States | $0.648B | 11.93 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.598B | 102.50 |
| Nutex Health (NUTX) | United States | $0.515B | 7.80 |
| Agilon Health (AGL) | United States | $0.501B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.482B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 7.01 |
| SBC Medicals (SBC) | United States | $0.413B | 9.07 |
| So-Young (SY) | China | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.411B | 27.03 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.391B | 0.00 |
| Oncology Institute (TOI) | United States | $0.334B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.157B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.116B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| KindlyMD (NAKA) | United States | $0.076B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| ModivCare (MODV) | United States | $0.027B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |